- Novo Nordisk shares jump 5% as drugmaker sees copycat Wegovy sales easing in 2025 CNBC
- Wegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off The Guardian
- Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast Yahoo Finance
- Novo Nordisk shares up on hopes for US Wegovy recovery after forecasts cut Reuters
- Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales WSJ
from "news" - Google News https://ift.tt/Eh9g2Db
No comments:
Post a Comment